KHAN; Iram F.
Patent Applications and Registrations
Patent applications and USPTO patent grants for KHAN; Iram F..The latest application filed is for "talen-based and crispr/cas-based gene editing for bruton's tyrosine kinase".
- KHAN; Iram F. - Issaquah WA
- Khan; Iram F. - Seattle WA
| Patent | Date |
|---|---|
| Talen-based And Crispr/cas-based Gene Editing For Bruton's Tyrosine Kinase App 20220064651 - RAWLINGS; David J. ; et al. | 2022-03-03 |
| Therapeutic Genome Editing In X-linked Hyper Igm Syndrome App 20210324381 - Rawlings; David J. ; et al. | 2021-10-21 |
| Expression Of Human Foxp3 In Gene Edited T Cells App 20210253652 - Scharenberg; Andrew M. ; et al. | 2021-08-19 |
| Bruton's Tyrosine Kinase Homing Endonuclease Variants, Compositions, And Methods Of Use App 20210230565 - RAWLINGS; David J. ; et al. | 2021-07-29 |
| Expression Of Foxp3 In Edited Cd34+ Cells App 20210054376 - Rawlings; David J. ; et al. | 2021-02-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 